blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Extract from the Register of European Patents

EP About this file: EP2219614

EP2219614 - PHARMACEUTICAL COMPOSITION OF ORLISTAT [Right-click to bookmark this link]
StatusThe application is deemed to be withdrawn
Status updated on  26.04.2013
Database last updated on 14.09.2024
Most recent event   Tooltip26.04.2013Application deemed to be withdrawnpublished on 29.05.2013  [2013/22]
Applicant(s)For all designated states
Inventis DDS Pvt Limited
6-3-1239/2 Amar House 4th Floor Raj Bhavan Road Somajiguda
Hyderabad 500 082 / IN
[2010/34]
Inventor(s)01 / PANDEY, H., C.
2-1-55/2 Venkateswara Colony Uppal
Hyderabad 500 039 / IN
02 / RADHAKRISHNAN, R., B.
42 Ameerline Bommidi (PO) Pappireddi Patti (TK) Dharmapuri (DT)
Tamilnadu 635301 / IN
03 / MOHAMMED, Sariha, Farnaaz
House no. 1-6-763 Musheerabad
Hyderabad 500020 / IN
04 / VAGHELA, Dipali
F/21 Uday Row House Opp. Vastrapur Rly. Crossing Vejalpur
Ahmedabad 380051 / IN
05 / LAKSHMI NARAYANA, Reddy Golamaru
Plot No. 17, Road No. 3, Tulasi Nagar Pragathi Nagar Road, Opposite to JNTU, Kukatpally
Hyderabad 500 072 Andhra Pradesh / IN
 [2010/34]
Representative(s)Tostmann, Holger Carl
Wallinger Ricker Schlotter Tostmann
Patent- und Rechtsanwälte Partnerschaft mbB
Zweibrückenstrasse 5-7
80331 München / DE
[N/P]
Former [2010/34]Tostmann, Holger Carl
Wallinger Ricker Schlotter Foerstl Patent- und Rechtsanwälte Zweibrückenstrasse 5-7
80331 Munich / DE
Application number, filing date07859603.815.10.2007
[2010/34]
WO2007IN00482
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report
No.:WO2009050720
Date:23.04.2009
Language:EN
[2009/17]
Type: A1 Application with search report 
No.:EP2219614
Date:25.08.2010
Language:EN
The application published by WIPO in one of the EPO official languages on 23.04.2009 takes the place of the publication of the European patent application.
[2010/34]
Search report(s)International search report - published on:EP23.04.2009
ClassificationIPC:A61K9/16, A61K9/20, A61K31/365, A61K47/10, A61K47/38
[2010/34]
CPC:
A61K31/365 (EP,US); A61K9/1676 (EP,US); A61K9/2054 (EP,US);
A61P3/04 (EP)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   MT,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2010/34]
TitleGerman:PHARMAZEUTISCHE ZUSAMMENSETZUNG VON ORLISTAT[2010/34]
English:PHARMACEUTICAL COMPOSITION OF ORLISTAT[2010/34]
French:COMPOSITION PHARMACEUTIQUE D'ORLISTAT[2010/34]
Entry into regional phase17.05.2010National basic fee paid 
17.05.2010Designation fee(s) paid 
17.05.2010Examination fee paid 
Examination proceduredeletedCommunication of intention to grant the patent
13.08.2009Request for preliminary examination filed
International Preliminary Examining Authority: EP
17.05.2010Examination requested  [2010/34]
26.07.2010Amendment by applicant (claims and/or description)
20.07.2012Despatch of a communication from the examining division (Time limit: M04)
01.12.2012Application deemed to be withdrawn, date of legal effect  [2013/22]
14.01.2013Despatch of communication that the application is deemed to be withdrawn, reason: reply to the communication from the examining division not received in time  [2013/22]
Divisional application(s)The date of the Examining Division's first communication in respect of the earliest application for which a communication has been issued is  20.07.2012
Fees paidRenewal fee
17.05.2010Renewal fee patent year 03
26.10.2010Renewal fee patent year 04
18.10.2011Renewal fee patent year 05
Penalty fee
Additional fee for renewal fee
31.10.201206   M06   Not yet paid
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court
See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Cited inInternational search[X]WO0200201  (HOFFMANN LA ROCHE [CH]) [X] 1-7 * page 2, line 21 - page 3, line 6; example 1; claims 1,7,17-19 *;
 [X]EP0638317  (HOFFMANN LA ROCHE [CH]) [X] 1-7 * example D; claims 1-9 *;
 [X]WO2006104397  (PROTEMIX CORP LTD [NZ], et al) [X] 1-7 * examples 28,29,33-35; claims 11,41 *;
 [X]WO02098413  (HOFFMANN LA ROCHE [CH]) [X] 1-7 * page 2, line 8 - line 16; claim 11 *;
 [X]US2007191351  (COWEN NEIL M [US], et al) [X] 1-7 * paragraphs [0361] , [0364] - [0366]; examples 1,2 *;
 [A]WO0209815  (HOFFMANN LA ROCHE [CH]) [A] 1-7 * page 4, line 15 - line 30 * * page 12, line 23 - line 32; claims 1-3 *;
 [A]WO9834630  (HOFFMANN LA ROCHE [CH]) [A] 1-7 * abstract *
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.